All stories tagged :

Pr Newswire

Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer

admin
Pr Newswire

HanAll Biopharma Reports Q2 2024 Financial Results and Provides Business Update

admin
Pr Newswire

2024 CICC GBA Wealth Management Forum successfully held in Hong Kong

admin
Pr Newswire

GMIF2024 Innovation Summit Invites All to Gather in Shenzhen on September...

admin
Pr Newswire

BRI Prudent Strategy Yields IDR29.90 Trillion Profit in Q2 2024

admin
Pr Newswire

OnKure Announces the Appointment of Dylan Hartley as Chief Scientific Officer

admin
Pr Newswire

BioAtla Highlighted Clinical Program and Pipeline Updates at Virtual R&D Day

admin
Pr Newswire

23andMe to Report Q1 FY2025 Financial Results

admin
Pr Newswire

Travere Therapeutics to Report Second Quarter 2024 Financial Results

admin
Pr Newswire

FDA Grants Orphan Drug and Rare Pediatric Disease Designation Status to...

admin
Pr Newswire

STONE Accounting Group Announces Strategic Rebranding and Business Expansion

admin

Featured

Pr Newswire

Inspire Medical Systems, Inc. to Report Second Quarter 2025 Financial Results...

admin
Pr Newswire

JenaValve’s Trilogy™ THV System Procedures Live Broadcast at New York Valves...

admin
People

REsimpli Launches Game-Changing AI-Powered CRM Tools for Real Estate Investors

admin
People

The World’s Most Prestigious Street Pole Vault Competition Comes to Asia!

admin
admin

Inspire Medical Systems, Inc. to Report Second Quarter 2025 Financial Results...

MINNEAPOLIS, July 07, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2025 after the close of trading on Monday, August 4. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time...